Daclizumab: a novel therapeutic option in severe bullous pemphigoid
DOI:
https://doi.org/10.1080/00015550410022221Abstract
No abstract availableDownloads
Download data is not yet available.
Downloads
Published
2005-01-26
How to Cite
Mockenhaupt, M., Grosber, M., & Norganer, J. (2005). Daclizumab: a novel therapeutic option in severe bullous pemphigoid. Acta Dermato-Venereologica, 85(1), 65–66. https://doi.org/10.1080/00015550410022221
Issue
Section
Articles
License
All digitalized ActaDV contents is available freely online. The Society for Publication of Acta Dermato-Venereologica owns the copyright for all material published until volume 88 (2008) and as from volume 89 (2009) the journal has been published fully Open Access, meaning the authors retain copyright to their work.
Unless otherwise specified, all Open Access articles are published under CC-BY-NC licences, allowing third parties to copy and redistribute the material in any medium or format and to remix, transform, and build upon the material for non-commercial purposes, provided proper attribution to the original work.
